三生国健股价涨5.07%，泰信基金旗下1只基金重仓，持有10万股浮盈赚取30.3万元

Group 1 - The core viewpoint of the news is that Sanofi Guojian's stock price increased by 5.07%, reaching 62.84 CNY per share, with a trading volume of 248 million CNY and a turnover rate of 0.65%, resulting in a total market capitalization of 38.759 billion CNY [1] - Sanofi Guojian Pharmaceutical (Shanghai) Co., Ltd. is located in the China (Shanghai) Free Trade Zone and was established on January 25, 2002, with its listing date on July 22, 2020. The company's main business involves the research, production, and sales of antibody drugs [1] - The revenue composition of Sanofi Guojian includes 75.24% from product sales, 15.37% from commissioned processing services, 7.94% from licensing services, and 1.44% from leasing services [1] Group 2 - From the perspective of fund holdings, one fund under Taixin Fund has a significant position in Sanofi Guojian. The Taixin Medical Service Mixed Fund A (013072) reduced its holdings by 114,800 shares in the third quarter, holding 100,000 shares, which accounts for 4.51% of the fund's net value, ranking as the eighth largest holding [2] - The Taixin Medical Service Mixed Fund A (013072) was established on December 29, 2021, with a latest scale of 19.9853 million CNY. Year-to-date returns are 8.65%, ranking 1331 out of 8836 in its category; the one-year return is 35.53%, ranking 3965 out of 8091; and since inception, the return is 18.21% [2] - The fund manager of Taixin Medical Service Mixed Fund A (013072) is Chen Ying, who has been in the position for 3 years and 363 days, with a total asset scale of 540 million CNY. The best fund return during the tenure is 23.53%, while the worst return is -6.33% [3]